Evidence Aggregation for Treatment Choice

Fuente: arXiv
Guardado en:
Detalles Bibliográficos
Autores principales: Ishihara, Takuya, Kitagawa, Toru
Formato: Preprint
Publicado: 2021
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1866914856519598080
author Ishihara, Takuya
Kitagawa, Toru
author_facet Ishihara, Takuya
Kitagawa, Toru
contents Consider a planner who has limited knowledge of the policy's causal impact on a certain local population of interest due to a lack of data, but does have access to the publicized intervention studies performed for similar policies on different populations. How should the planner make use of and aggregate this existing evidence to make her policy decision? Following Manski (2020; Towards Credible Patient-Centered Meta-Analysis, \textit{Epidemiology}), we formulate the planner's problem as a statistical decision problem with a social welfare objective, and solve for an optimal aggregation rule under the minimax-regret criterion. We investigate the analytical properties, computational feasibility, and welfare regret performance of this rule. We apply the minimax regret decision rule to two settings: whether to enact an active labor market policy based on 14 randomized control trial studies; and whether to approve a drug (Remdesivir) for COVID-19 treatment using a meta-database of clinical trials.
format Preprint
id arxiv_https___arxiv_org_abs_2108_06473
institution arXiv
publishDate 2021
record_format arxiv
spellingShingle Evidence Aggregation for Treatment Choice
Ishihara, Takuya
Kitagawa, Toru
Econometrics
Statistics Theory
Consider a planner who has limited knowledge of the policy's causal impact on a certain local population of interest due to a lack of data, but does have access to the publicized intervention studies performed for similar policies on different populations. How should the planner make use of and aggregate this existing evidence to make her policy decision? Following Manski (2020; Towards Credible Patient-Centered Meta-Analysis, \textit{Epidemiology}), we formulate the planner's problem as a statistical decision problem with a social welfare objective, and solve for an optimal aggregation rule under the minimax-regret criterion. We investigate the analytical properties, computational feasibility, and welfare regret performance of this rule. We apply the minimax regret decision rule to two settings: whether to enact an active labor market policy based on 14 randomized control trial studies; and whether to approve a drug (Remdesivir) for COVID-19 treatment using a meta-database of clinical trials.
title Evidence Aggregation for Treatment Choice
topic Econometrics
Statistics Theory
url https://arxiv.org/abs/2108.06473